俞雪莲;张曦;

• 1:上海市疾病预防控制中心

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation): 上海市人才发展资金(资金编号:2009042);; 上海市自然科学基金资助(项目编号:09ZR1426800)

作者(Authors): 俞雪莲;张曦;

DOI: 10.13242/j.cnki.bingduxuebao.002073

参考文献(References)：

• [1]Berns KI.Parvoviridae:the viruses and their replication[M]//Fields B N,Knipe D M,Howley P M,et al.Fields virology:3rd ed.Philadelphia:Lippincott-Raven,1996:2173-2197.
• [2]Berns KI,Bohenzky R A.Adeno-associated viruses:an update[J].Adv Virus Res,1987,32:243-306.
• [3]Heegaard E D,Brown K E.Human parvovirus B19[J].Clin Microbiol Rev,2002,15(3):485-505.
• [4]Jones MS,Kapoor A,Lukashov V V,et al.New DNA viruses identified in patients with acute viral infection syndrome[J].J Virol,2005,79(13):8230-8236.
• [5]Allander T,Tammi MT,Eriksson M,et al.Cloning of a human parvovirus by molecular screening of respiratory tract samples[J].Proc Natl Acad Sci USA,2005,102(36):12891-12896.
• [6]Ozawa K,Young N.Characterization of capsid and non-capsid proteins of B19parvovirus propagated in human erythroid bone marrow cell cultures[J].J Virol,1987,61(8):2627-2630.
• [7]Nakashi ma A,Morita E,Saito S,et al.Human Parvo-virus B19nonstructural protein transactivates the p21/WAF1through Sp1[J].Virology,2004,329(2):493-504.
• [8]Hemauer A,von Poblotzki A,Gigler A,et al.Sequence variability among different parvovirus B19isolates[J].J Gen Virol,1996,77(Pt8):1781-1785.
• [9]Umene K,Nunoue T.The genome type of human parvo-virus B19strains isolated in Japan during1981differs fromtypes detected in1986to1987:a correlation be-tween genome type and prevalence[J].J Gen Virol,1990,71(Pt4):983-986.
• [10]Enders M,Weidner A,Enders G.Current epidemio-logical aspects of human parvovirus B19infection during pregnancy and childhood in the western part of Germa-ny[J].Epidemiol Infect,2007,135(4):563-569.
• [11]Broliden K,Tolfvenstam T,Norbeck O.Clinical as-pects of parvovirus B19infection[J].J Intern Med,2006,260(4):285-304.
• [12]Takahashi Y,Murai C,Ishii T,et al.Human parvo-virus B19in rheumatoid arthritis[J].Int Rev I mmunol,1998,17(5-6):309-321.
• [13]Barah F,Vallely P J,Cleator G M,et al.Neurological manifestations of human parvovirus B19infection[J].Rev Med Virol,2003,13(3):185-199.
• [14]Bock C T,Klingel K,Aberle S,et al.Human parvo-virus B19:a new emerging pathogen of inflammatory cardiomyopathy[J].J Vet Med B Infect Dis Vet Public Health,2005,52(7-8):340-343.
• [15]Brown K E,Young N S.Human parvovirus B19infec-tions ininfants and children[J].Adv Pediatr Infect Dis,1997,13:101-126.
• [16]Kelly H A,Siebert D,Hammond R,et al.The age-specific prevalence of human parvovirus i mmunity in Victoria,Australia compared with other parts of the world[J].Epidemiol Infect,2000,124(3):449-457.
• [17]Koch W C,Adler S P.Human parvovirus B19infec-tions in women of childbearing age and within families[J].Pediatr Infect Dis J,1989,8(2):83-87.
• [18]Matsukura H,Shibata S,Tani Y,et al.Persistent in-fection by human parvovirus B19in qualified blood do-nors[J].Transfusion,2008,48(5):1036-1037.
• [19]Ozawa K,Kurtzman G,Young N.Replication of the B19parvovirus in human bone marrowcell cultures[J].Science,1986,233(4766):883-886.
• [20]Schwarz T F,Serke S,Hottentrager B,et al.Replica-tion of parvovirus B19in hematopoietic progenitor cells generatedin vitrofrom normal human peripheral blood[J].J Virol,1992,66(2):1273-1276.
• [21]Sosa C E,Mahony J B,Luinstra K E,et al.Replica-tion and cytopathology of human parvovirus B19in hu-man umbilical cord blood erythroid progenitor cells[J].J Med Virol,1992,36(2):125-130.
• [22]Miyagawa E,Yoshida T,Takahashi H,et al.Infection of the erythroid cell line,KU812Ep6with human par-vovirus B19and its application to titration of B19infec-tivity[J].J Virol Methods,1999,83(1-2):45-54.
• [23]Munshi N C,Zhou S,Woody MJ,et al.Successful replication of parvovirus B19in the human megakaryo-cytic leukemia cell line MB-02[J].J Virol,1993,67(1):562-566.
• [24]Shi momura S,Komatsu N,Frickhofen N,et al.First continuous propagation of B19parvovirus in a cell line[J].Blood,1992,79(1):18-24.
• [25]Takahashi T,Ozawa K,Takahashi K,et al.DNArep-lication of parvovirus B19in a human erythroidleukemia cell line(JK-1)in vitro[J].Arch Virol,1993,131(1-2):201-208.
• [26]Bostic J R,Brown K E,Young NS,et al.Quantitative analysis of neutralizing i mmune responses to human parvovirus B19using a novel reverse transcriptase-poly-merase chain reaction-based assay[J].J Infect Dis,1999,179(3):619-626.
• [27]Koch WC,Massey G,Russell C E,et al.Manifesta-tions and treat ment of human parvovirus B19infection ini mmunocompromised patients[J].J Pediatr,1990,116(3):355-359.
• [28]van Elsacker-Neile A M,Kroon F P,van der Ende M E,et al.Prevalence of parvovirus B19infection in pa-tients infected with human i mmunodeficiency virus[J].Clin Infect Dis,1996,23(6):1255-1260.
• [29]Chernak E,Dubin G,Henry D,et al.Infection due to parvovirus B19in patients infected with human i[J]mmunodeficiency virus[J].Clin Infect Dis,1995,20(1):170-173.
• [30]Sokal E M,Melchior M,Cornu C,et al.Acute parvo-virus B19infection associated with ful minant hepatitis of favourable prognosis in young children[J].Lancet,1998,352(9142):1739-1741.
• [31]Yoto Y,Kudoh T,Haseyama K,et al.Human parvo-virus B19infection associated with acute hepatitis[J].Lancet,1996,347(9005):868-869.
• [32]Wong S,Young NS,Brown K E.Prevalence of parvo-virus B19in liver tissue:no association with ful minant hepatitis or hepatitis-associated aplastic anemia[J].J Infect Dis,2003,187(10):1581-1586.
• [33]Hsu T C,Chen T Y,Lin MC,et al.Human parvovir-us B19infection in patients with chronic hepatitis B or hepatitis C infection[J].J Gastroenterol Hepatol,2005,20(5):733-738.
• [34]Toan N L,Song le H,Kremsner P G,et al.Co-infec-tion of human parvovirus B19in Vietnamese patients with hepatitis B virus infection[J].J Hepatol,2006,45(3):361-369.
• [35]Srivastava A,Bruno E,Briddell R,et al.Parvovirus B19-induced perturbation of human megakaryocytopoie-sisin vitro[J].Blood,1990,76(10):1997-2004.
• [36]Sol N,Morinet F,Alizon M,et al.Trans-activation of the long terminal repeat of humani mmunodeficiency vi-rus type1by the parvovirus B19NS1gene product[J].J Gen Virol,1993,74(Pt9):2011-2014.
• [37]Poole B D,Karetnyi Y V,Naides S J.Parvovirus B19-induced apoptosis of hepatocytes[J].J Virol,2004,78(14):7775-7783.
• [38]Poole B D,Zhou J,Grote A,et al.Apoptosis of liver-derived cells induced by parvovirus B19nonstructural protein[J].J Virol,2006,80(8):4114-4121.
• [39]Fu Y,Ishii K K,Munakata Y,et al.Regulation of tumor necrosis factor alpha promoter by human parvo-virus B19NS1through activation of AP-1and AP-2[J].J Virol,2002,76(11):5395-5403.
• [40]Hsu T C,Tzang B S,Huang C N,et al.Increased ex-pression and secretion of interleukin-6in human parvo-virus B19non-structural protein(NS1)transfected COS-7epithelial cells[J].Clin Exp I mmunol,2006,144(1):152-157.
• [41]Von Poblotzki A,Hemaner A,Gigler A,et al.Antibod-ies to the nonstructural protein of parvovirus B19in persistently infected patients:i mplications for pathogen-esis.J Infect Dis,1995,172(5):1356-1359.
• [42]Fryer J F,Kapoor A,Minor P D,et al.Novel parvo-virus and related variant in human plasma[J].Emerg Infect Dis,2006,12(1):151-154.
• [43]Fryer J F,Del wart E,Hecht F M,et al.Frequent de-tection of the parvoviruses,PARV4and PARV5,inplasma from blood donors and symptomatic individuals[J].Transfusion,2007,47(6):1054-1061.
• [44]Schneider B,Fryer J F,Oldenburg J,et al.Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4[J].J Med Virol,2008,80(2):345-351.
• [45]Hokynar K,Soderlund-Venermo M,Pesonen M,et al.A new parvovirus genotype persistent in human skin[J].Virology,2002,302(2):224-228.
• [46]Nguyen Q T,Sifer C,Schneider V,et al.Novel human erythrovirus associated with transient aplastic anemia[J].J Clin Microbiol,1999,37(8):2483-2487.
• [47]Si mmonds P,Douglas J,Bestetti G,et al.Athird gen-otype of the human parvovirus PARV4in sub-Saharan Africa[J].J Gen Virol,2008,89(Pt9):2299-2302.
• [48]Si mmonds P,Manning A,Kenneil R,et al.Parenteral transmission of the novel human parvovirus PARV4[J].Emerg Infect Dis,2007,13(9):1386-1388.
• [49]Longhi E,Bestetti G,Acquaviva V,et al.Human par-vovirus4in the bone marrow of Italian patients with AIDS[J].Aids,2007,21(11):1481-1483.
• [50]Sharp C P,Lail A,Donfield S,et al.High frequencies of exposure to the novel human parvovirus PARV4in hemophiliacs and injection drug users,as detected by a serological assay for PARV4antibodies[J].J Infect Dis,2009,200(7):1119-1125.
• [51]Fryer J F,Hubbard A R,Baylis S A.Human parvovir-us PARV4in clotting factorⅧconcentrates[J].Vox Sang,2007,93(4):341-347.
• [52]Botto S,Bergallo M,Sidoti F,et al.Detection of PARV4,genotypes1and2,in healthy and pathological clinical speci mens[J].New Microbiol,2009,32(2):189-192.
• [53]Manning A,Willey S J,Bell J E,et al.Comparison of tissue distribution,persistence,and molecular epidemi-ology of parvovirus B19and novel human parvoviruses PARV4and human bocavirus[J].J Infect Dis,2007,195(9):1345-1352.
• [54]Fryer J F,Lucas S B,Padley D,et al.Parvoviruses PARV4/5in hepatitis C virus-infected patient[J].Emerg Infect Dis,2007,13(1):175-176.
• [55]Schneider B,Fryer J F,Reber U,et al.Persistence of novel human parvovirus PARV4inliver tissue of adults[J].J Med Virol,2008,80(2):345-351.
• [56]Goldstein S T,Zhou F,Hadler S C,et al.A mathe-matical model to esti mate global hepatitis B disease bur-den and vaccinationi mpact[J].Int J Epidemiol,2005,34(6):1329-1339.
• [57]Jia J D,Zhuang H.The overview of the seminar on chronic hepatitis B[J].Chin J Hepatol,2004,(12):698-699.
• [58]Zhou Y H,Wu C,Zhuang H.Vaccination against hep-atitis B:the Chinese experience[J].Chin Med J,2008,121(1):98-102.